B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRB2

MOLECULAR TARGET

adrenoceptor beta 2

UniProt: P07550NCBI Gene: 15482 compounds

ADRB2 (adrenoceptor beta 2) is targeted by 82 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRB2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on3.9752
2Propranolol3.5634
3Levalbuterol3.3728
4Levalbuterol3.3728
5Alprenolol3.0921
6Epinephrine2.8316
7Norepinephrine Precursor of epinephrine that is secreted by2.8316
8Levalbuterol2.6413
9Atenolol2.5612
10Pindolol2.5612
11Timolol2.4811
12Reserpine2.4010
13Bupranolol2.309
14Chlorhexidine2.309
15Clenbuterol2.309
16Fenoterol2.087
17Nadolol2.087
18Carvedilol1.956
19Practolol1.956
20Sotalol1.956
21Aripiprazole1.795
22Bisoprolol1.795
23Fluspirilene1.795
24Hexachlorophene1.795
25Ranolazine1.795
26Salmeterol Xinafoate1.795
27Terbutaline1.795
28Astemizole Antihistamine drug now withdrawn from1.614
29Bunolol1.614
30Cyclic AMP1.614
31Cyclic AMP1.614
32Domperidone1.614
33Doxazosin1.614
34Hydroxyzine1.614
35Loratadine1.614
36Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is1.614
37Nicergoline1.614
38Nisoldipine1.614
39Nylidrin1.614
40o-Phthalaldehyde1.614
41Xamoterol1.614
42Anisomycin1.393
43Carteolol1.393
44Clotrimazole1.393
45Dinitrochlorobenzene1.393
46Metaproterenol1.393
47Phenylephrine1.393
48Acebutolol1.102
49Celecoxib1.102
50Celiprolol1.102

Showing top 50 of 82 compounds. Use the BiohacksAI search to explore all ADRB2 modulators.

About ADRB2 as a Drug Target

ADRB2 (adrenoceptor beta 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 82 compounds with documented ADRB2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRB2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.